arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 2/2022 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Omicron variant: how well do COVID-19 vaccines protect against hospitalizations?

    Reasons of the delivery failure of tamoxifen

    NEW ON THE MARKET

    Protein vaccine NVX-CoV2373 (NUVAXOVID) against SARS-CoV-2

    Sotrovimab (XEVUDY) against COVID-19

    PALFORZIA against peanut allergy

    IN BRIEF

    On the promotion of rebated drugs by BARMER

    E-cigarettes: risk of passive exposure
    free

    Court bans NEURASAN advertising

    SIDE EFFECTS

    Hydroxyethyl starch (e.g. VOLUVEN): market withdrawal recommended again

    e a-t ON THE INTERNET

    Sotrovimab (XEVUDY) against COVID-19 (long version)

    PALFORZIA against peanut allergy (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!